The effect of initial recognition of abnormalities by physicians on outcome of retinoblastoma
- PMID: 16102491
- DOI: 10.1016/j.jaapos.2005.02.013
The effect of initial recognition of abnormalities by physicians on outcome of retinoblastoma
Abstract
Purpose: The purpose of this study was to assess the effect of early diagnosis by physicians on outcome of retinoblastoma.
Methods: This was an observational case series in which the records of 36 patients with retinoblastoma were reviewed. The age at onset of first symptoms and diagnosis, identity of the individual who first recognized an abnormality, treatment, and outcome were analyzed.
Results: Twenty-two patients had unilateral retinoblastoma. Both eyes were preserved in only 2 of these patients, both of whom had abnormalities first noted by their pediatricians. Fourteen patients had bilateral retinoblastoma. Both eyes were preserved in the 5 bilateral patients who were monitored from birth with serial examinations under anesthesia because of family histories of retinoblastoma. Enucleation of at least 1 eye was required in 8 of the 9 bilateral patients whose families first noted abnormalities. Enucleation of at least 1 eye was required in 27 of 28 patients (96%) in whom abnormalities were first noted by parents.
Conclusion: In this series, the only patients with unilateral retinoblastoma who did not require enucleation were those in whom pediatricians, rather than family members, first noted ocular abnormalities. Both eyes were preserved in all patients with bilateral retinoblastoma who underwent serial examinations under anesthesia because of family histories of retinoblastoma. The prognosis for retinoblastoma appears to be greatly improved when physicians initially detect abnormalities. Educational efforts directed at early detection of retinoblastoma by pediatricians and other primary care providers should be encouraged.
Similar articles
-
Outcome of eyes with unilateral sporadic retinoblastoma based on the initial external findings by the family and the pediatrician.J Pediatr Ophthalmol Strabismus. 2004 May-Jun;41(3):143-9; quiz 172-3. doi: 10.3928/0191-3913-20040501-06. J Pediatr Ophthalmol Strabismus. 2004. PMID: 15206599 Review.
-
Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye.Br J Ophthalmol. 2018 Feb;102(2):265-271. doi: 10.1136/bjophthalmol-2017-310624. Epub 2017 Jun 28. Br J Ophthalmol. 2018. PMID: 28659391
-
Clinical spectrum of diffuse infiltrating retinoblastoma in 34 consecutive eyes.Ophthalmology. 2008 Dec;115(12):2253-8. doi: 10.1016/j.ophtha.2008.07.003. Epub 2008 Oct 29. Ophthalmology. 2008. PMID: 18962920
-
Management and outcome of unilateral retinoblastoma.J AAPOS. 2009 Dec;13(6):546-50. doi: 10.1016/j.jaapos.2009.09.004. J AAPOS. 2009. PMID: 20006813
-
Orbital implants in retinoblastoma patients: 23 years of experience and a review of the literature.Acta Ophthalmol. 2016 Mar;94(2):165-74. doi: 10.1111/aos.12915. Epub 2015 Nov 25. Acta Ophthalmol. 2016. PMID: 26603132 Review.
MeSH terms
LinkOut - more resources
Full Text Sources